Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GE HealthCare Technologies Inc. - Common Stock (NQ: GEHC )

86.95 -0.40 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GE HealthCare Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
GE HealthCare reports third quarter 2024 financial results
From GE HealthCare
Via Business Wire
GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
From GE HealthCare
Via Business Wire
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
From GE HealthCare
Via Business Wire
GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes
From GE HealthCare
Via Business Wire
GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center
From GE HealthCare Technologies Inc.
Via Business Wire
A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
From GE HealthCare
Via Business Wire
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
From GE HealthCare
Via Business Wire
GE HealthCare to announce third quarter 2024 results on October 30, 2024
From GE HealthCare
Via Business Wire
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
From GE HealthCare
Via Business Wire
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
From GE HealthCare
Via Business Wire
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
From GE HealthCare
Via Business Wire
GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare announces cash dividend for third quarter of 2024
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024
From GE HealthCare
Via Business Wire
GE HealthCare management to present at September investor conferences
From GE HealthCare Technologies Inc.
Via Business Wire
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
From GE HealthCare
Via Business Wire
GE HealthCare to Embark on a Collaboration to Elevate Women’s Imaging
From GE HealthCare
Via Business Wire
GE HealthCare reports second quarter 2024 financial results
From GE HealthCare
Via Business Wire
GE HealthCare and AWS Announce Strategic Collaboration to Accelerate Healthcare Transformation With Generative AI
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare to announce second quarter 2024 results on July 31, 2024
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare announces cash dividend for second quarter of 2024
From GE HealthCare Technologies Inc.
Via Business Wire
Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures
From GE HealthCare
Via Business Wire
GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology
From GE HealthCare
Via Business Wire
GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers
From GE HealthCare
Via Business Wire
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
From GE HealthCare
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.